Department of Urology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA 90095, USA. jgore@mednet.ucla.edu
BACKGROUND: A 66-year-old man with hypertension, hyperlipidemia, and benign prostatic hyperplasia presented for evaluation of an elevated PSA level of 6.2 ng/ml. INVESTIGATIONS: Transrectal ultrasound-guided 12-core prostate needle biopsy. DIAGNOSIS: Clinically localized, clinical stage T1c adenocarcinoma of the prostate. MANAGEMENT: Following a full discussion of the risks and benefits of his treatment options, including quality-of-life sequelae, the patient opted for radical prostatectomy.